Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease

Schär, Manuel Y., Curtis, Peter J., Hazim, Sara, Ostertag, Luisa M., Kay, Colin D., Potter, John F. and Cassidy, Aedín (2015) Orange juice-derived flavanone and phenolic metabolites do not acutely affect cardiovascular risk biomarkers: a randomized, placebo-controlled, crossover trial in men at moderate risk of cardiovascular disease. The American Journal of Clinical Nutrition, 101 (5). pp. 931-938. ISSN 0002-9165

[img] PDF (Acceptance letter_AJCN_Flavanone paper) - Draft Version
Restricted to Repository staff only until 31 December 2099.

Download (93kB) | Request a copy

Abstract

Epidemiologic data suggest inverse associations between citrus flavanone intake and cardiovascular disease (CVD) risk. However, insufficient randomized controlled trial data limit our understanding of the mechanisms by which flavanones and their metabolites potentially reduce cardiovascular risk factors.

Item Type: Article
Uncontrolled Keywords: flavonoids,flavanones,phenolic metabolites,randomized controlled trial,vascular function
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: Pure Connector
Date Deposited: 24 Jul 2015 22:45
Last Modified: 22 Apr 2020 00:14
URI: https://ueaeprints.uea.ac.uk/id/eprint/53685
DOI: 10.3945/ajcn.114.104364

Actions (login required)

View Item View Item